Comparison of the degenerative and inflammatory markers in cerebrospinal fluid in multiple sclerosis patients with relapsing-remitting course of disease and after clinically isolated syndrome

被引：0
|
作者：
Sladkova, Vladimira [1 ]
Mares, Jan [1 ]
Lubenova, Blanka [1 ]
Kollarova, Katarina [1 ]
Kanovsky, Petr [1 ]
机构：
[1] Univ Hosp Olomouc, Dept Neurol, Olomouc, Czech Republic
来源：
MULTIPLE SCLEROSIS | 2008年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S287 / S288
页数：2
相关论文
共 50 条
  • [21] Prevalence of of cognitive impairment among Hungarian patients with relapsing-remitting multiple sclerosis and clinically isolated syndrome
    Daniel, Sandi
    Tamas, Biernacki
    Szekeres, Dora
    Judit, Fuvesi
    Kincses, Zsigmond Tamas
    Csilla, Rozsa
    Matyas, Klotild
    Krisztian, Kasa
    Judit, Matolcsi
    Zboznovits, Dora
    Zita, Burany
    Eva, Langane
    Laszlo, Vecsei
    Krisztina, Bencsik
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 17 : 57 - 62
  • [22] Changes of oligoclonal band number in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
    Mares, J.
    Kanovsky, P.
    Herzig, R.
    Urbanek, K.
    Dolezil, D.
    Sladkova, V.
    Lubenova, B.
    Bekarek, V.
    Sklenarova, J.
    Zapletalova, J.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S82 - S82
  • [23] Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis
    Alcázar, A
    Regidor, I
    Masjuan, J
    Salinas, M
    Alvarez-Cermeño, JC
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 104 (01) : 58 - 67
  • [24] Expression of apoptosis-related genes in relapsing-remitting multiple sclerosis and clinically isolated syndrome
    Hagman, S.
    Caliskan, R.
    Helminen, M.
    Dastidar, P.
    Elovaara, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 349 - 349
  • [25] Expression of apoptosis-related genes in relapsing-remitting multiple sclerosis and clinically isolated syndrome
    Hagman, S.
    Caliskan, R.
    Helminen, M.
    Dastidar, P.
    Elovaara, I.
    JOURNAL OF NEUROLOGY, 2014, 261 : S236 - S236
  • [26] Serum Leptin Levels in Treatment-Naive Patients with Clinically Isolated Syndrome or Relapsing-Remitting Multiple Sclerosis
    Evangelopoulos, Maria Eleftheria
    Koutsis, Georgios
    Markianos, Manolis
    AUTOIMMUNE DISEASES, 2014, 2014
  • [27] Risk Factors for Poor Adherence to Betaferon® Treatment in Patients with Relapsing-Remitting Multiple Sclerosis or Clinically Isolated Syndrome
    Jernas, Lukasz
    Wencel, Jacek
    Wiak, Andrzej
    Bieniek, Marek
    Bartosik-Psujek, Halina
    PLOS ONE, 2016, 11 (10):
  • [28] Expression of apoptosis-related genes in blood of clinically isolated syndrome and relapsing-remitting multiple sclerosis patients
    Sanna, Rinta
    Raunio, Minna
    Irina, Elovaara
    JOURNAL OF NEUROIMMUNOLOGY, 2010, 228 (1-2) : 10 - 10
  • [29] Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis
    Novakova, Lenka
    Axelsson, Markus
    Khademi, Mohsen
    Zetterberg, Henrik
    Blennow, Kaj
    Malmestrom, Clas
    Piehl, Fredrik
    Olsson, Tomas
    Lycke, Jan
    JOURNAL OF NEUROCHEMISTRY, 2017, 141 (02) : 296 - 304
  • [30] Composite cerebrospinal fluid score in relapsing-remitting and secondary progressive multiple sclerosis
    Jongen, PJH
    Floris, S
    Doesburg, WH
    Lemmens, WAJG
    Hommes, OR
    Lamers, KJB
    MULTIPLE SCLEROSIS, 1998, 4 (03): : 108 - 110
12345